Urate-Lowering Therapy May Reduce Type 2 Diabetes Risk in Patients With Gout
Researchers investigated the association between gout, urate-lowering therapy use, and the risk of developing type 2 diabetes.
Urate-Lowering Therapies
Genetically High Plasma Vitamin C Not Associated With Risk for Hyperuricemia
Data suggest that vitamin C supplementation should not be recommended to lower plasma urate.
Novel Uricosuric Drug Effectively Decreases Gout Flares vs Allopurinol
Arhalofenate, a novel uricosuric investigational drug, appears to be well-tolerated and significantly decreased the number of gout flares compared to allopurinol. If approved, it would be the first urate-lowering anti-flare therapy for gout.
Presence of Gouty Tophi Increases Risk of Cardiovascular Disease More Than Hypertension
The presence of tophi in people with gout was associated with increased risk for cardiovascular disease.
- Loading...
Loading...
Next post in Gout
Loading... 
Loading...